Načítá se...
Pityriasis Rubra Pilaris-Like Erythroderma Secondary to Phosphoinositide 3-Kinase Inhibition
IMPORTANCE: Phosphoinositide 3-kinase (PI3K) inhibitors are a class of small-molecule inhibitors approved for the treatment of certain leukemias and lymphomas. Their dermatologic side effect profile is poorly described. A detailed understanding of the cutaneous adverse events from PI3K inhibitors wi...
Uloženo v:
| Vydáno v: | Clin Exp Dermatol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996936/ https://ncbi.nlm.nih.gov/pubmed/29851132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ced.13608 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|